Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
about
Willingness to pay for prevention and treatment of lymphatic filariasis in Leogane, HaitiLymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmissionModeling the impact and costs of semiannual mass drug administration for accelerated elimination of lymphatic filariasisThe role of personal opinions and experiences in compliance with mass drug administration for lymphatic filariasis elimination in KenyaSequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New GuineaMaternal Infection Is a Risk Factor for Early Childhood Infection in FilariasisMapping of Bancroftian Filariasis in Cameroon: Prospects for EliminationThe importance of patient compliance in repeated rounds of mass drug administration (MDA) for the elimination of intestinal helminth transmission.First evidence of lymphatic filariasis transmission interruption in Cameroon: Progress towards eliminationMass drug administration for lymphatic filariasis elimination in a coastal state of India: a study on barriers to coverage and compliance.Modelling parasite drug resistance: lessons for management and control strategies.Advances and challenges in predicting the impact of lymphatic filariasis elimination programmes by mathematical modellingModelling strategies to break transmission of lymphatic filariasis--aggregation, adherence and vector competence greatly alter elimination.Compliance with anthelmintic treatment in the neglected tropical diseases control programmes: a systematic review.Mathematical modelling of lymphatic filariasis elimination programmes in India: required duration of mass drug administration and post-treatment level of infection indicators.Prospects for the control of neglected tropical diseases by mass drug administration.Predicting lymphatic filariasis transmission and elimination dynamics using a multi-model ensemble framework.Coverage of, and compliance with, mass drug administration under the programme to eliminate lymphatic filariasis in India: a systematic review.Measuring and modelling the effects of systematic non-adherence to mass drug administration.A programme to eliminate lymphatic filariasis in Tamil Nadu state, India: compliance with annual single-dose DEC mass treatment and some related operational aspects.Coverage, compliance and some operational issues of mass drug administration during the programme to eliminate lymphatic filariasis in Orissa, India.Factors influencing drug compliance in the mass drug administration programme against filariasis in the Western province of Sri Lanka.Ivermectin: a complimentary weapon against the spread of malaria?Pattern of community compliance with spaced, single-dose, mass administrations of diethylcarbamazine or ivermectin, for the elimination of lymphatic filariasis from rural areas of southern India.Effectiveness of community and health services-organized drug delivery strategies for elimination of lymphatic filariasis in rural areas of Tamil Nadu, India.LYMFASIM, a simulation model for predicting the impact of lymphatic filariasis control: quantification for African villages.Significant decrease in the prevalence of Wuchereria bancrofti infection in anopheline mosquitoes following the addition of albendazole to annual, ivermectin-based, mass treatments in Nigeria.Effectiveness of two annual, single-dose mass drug administrations of diethylcarbamazine alone or in combination with albendazole on soil-transmitted helminthiasis in filariasis elimination programme.Helminth lifespan interacts with non-compliance in reducing the effectiveness of anthelmintic treatment.Are Alternative Strategies Required to Accelerate the Global Elimination of Lymphatic Filariasis? Insights From Mathematical Models.Counting Down the 2020 Goals for 9 Neglected Tropical Diseases: What Have We Learned From Quantitative Analysis and Transmission Modeling?
P2860
Q24799349-A0214B80-759B-4570-B135-3E31FE24F2CCQ28474138-4972E487-90E8-400B-A5E3-9038D3527DF2Q28484840-BBB7A697-07C0-423F-A420-0BEC659CE558Q28485256-F9806898-4CF5-46CC-AFE7-E2ACA29ECA6BQ28534282-81BDFA01-A85F-4F4E-93EE-9EA982D78BABQ28546891-A34EB8AE-5CDD-4728-86D8-BD5F2D804BD2Q28547792-85493050-ED78-45C7-A12C-CF7527914E01Q33792347-13ED6C51-E5BA-45D9-AE57-85512B48CB81Q33852823-A1965EFB-6509-4EFB-9D55-58310749E5D9Q34198950-F44D4E8A-CEAA-45CD-AB0D-7CC2F67EA18DQ34434816-0CC654DF-996F-474E-82ED-AC5903217328Q34567530-E477901F-C090-4BE6-8F9B-FE47B7382141Q36201275-6E3945F6-CABA-4070-ADD7-F320DC5908C8Q36508829-6A019EF5-24CA-4CE4-AC30-5CAD2702ACD9Q37254795-0854DCCF-6D44-44E2-954C-8295066DFBBFQ37557676-144BE98B-0B9E-4BCE-915C-2F95DA5DE03CQ37685563-08A46CA2-8E27-4904-801F-E0FDD84ED09BQ38204263-5A98099C-C32B-4D1A-8F27-69841DB83644Q38916889-53F97229-40FD-4FB5-B043-B12436FD8416Q39557107-3E4882FF-0031-4A04-B93C-405068FA4077Q39687003-2E1CCC0F-1FE5-4A32-8DAC-3F23C53AC6B9Q39776253-99FEE974-BAE6-4304-9BF7-B33874A2FD25Q40411509-5461F612-6980-4645-BAA4-6E90ECAD3AD1Q40510797-AAB6F69B-98D3-465D-ABD4-8AC78DBBBF5BQ43818412-B736EAF7-6B2D-469F-8E8B-EF0848200BC4Q43943647-EE416B49-FDA4-4088-8347-A2B155058E50Q44164360-3E84383E-1519-4202-9AB8-37DE6945D82DQ45054072-A6361A3C-FDD7-4E93-9A69-262E19E85C2EQ47554674-090C27D9-EADB-4451-9497-50DEF24F2DF9Q54983273-E66087BB-D4F2-4FDF-B4E5-053DEE6EBC4EQ54987794-4040800B-1F31-4D13-AF32-2FDEBEF93E76
P2860
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@ast
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@en
type
label
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@ast
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@en
prefLabel
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@ast
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@en
P2093
P1476
Effectiveness of annual ivermectin treatment for Wuchereria bancrofti infection.
@en
P2093
Habbema JD
Plaisier AP
van Oortmarssen GJ
P304
P356
10.1016/S0169-4758(00)01691-4
P577
2000-07-01T00:00:00Z